Sildenafil Tablet, Film Coated
Product Images NDC 71205-220

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71205-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sildenafil Fig1)

A line graph depicting the mean change from baseline in sitting systolic blood pressure over 24 hours post-dose in healthy volunteers. It compares Sildenafil 100 mg with placebo, showing systolic blood pressure changes (mmHg) on the vertical axis and time post-dose (hours) on the horizontal axis, starting from pre-dose baseline.*

FDA Label Image

71205-220-10 (Sildenafil Fig10)

Label for Sildenafil 100 mg film-coated tablets by Proficient Rx LP, NDC 71205-220-10. The package contains 10 tablets. Tablets are white to off-white, diamond-shaped, biconvex, with 'T' debossed on one side and '30' on the other. Manufactured by Aurobindo Pharma Limited, India. Storage instructions and standard warnings are included.*

FDA Label Image

Figure 2 (Sildenafil Fig2)

A line graph depicting the mean standing systolic blood pressure change from baseline over an 8-hour period postdose. It compares two groups: one receiving Doxazosin with Placebo and the other receiving Doxazosin with Sildenafil 25 mg. The y-axis shows change in systolic blood pressure (mmHg) and the x-axis represents time in hours postdose.*

FDA Label Image

Figure 3 (Sildenafil Fig3)

A line graph depicting mean standing systolic blood pressure change from baseline over time postdose (hours). Two data series are shown: one for Doxazosin + Placebo and another for Doxazosin + Sildenafil 50 mg, with changes measured in mmHg across an 8-hour period.*

FDA Label Image

Figure 4 (Sildenafil Fig4)

A line graph showing mean standing systolic blood pressure change from baseline over 8 hours after dosing. It compares two groups: one receiving Doxazosin with Sildenafil 100 mg, and the other receiving Doxazosin with placebo. The vertical axis measures blood pressure change in mmHg, and the horizontal axis represents time in hours after dosing.*

FDA Label Image

Figure 5 (Sildenafil Fig5)

A line graph depicting mean plasma concentrations (ng/mL) of Sildenafil over time (hours) post dose in healthy male volunteers. It shows plasma concentration peaking shortly after administration and declining gradually over 24 hours, with data represented for a commercial tablet formulation.*

FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

Two bar graphs comparing the effect of Sildenafil versus placebo on maintenance of erection by baseline score. The top graph shows percentages of patients at endpoint across baseline scores (0 to 5) with Sildenafil, indicating increasing maintenance at higher baseline scores. The bottom graph shows similar data for placebo with more variable percentages across baseline scores. Each graph uses multiple shaded bars representing different categorical scores from 0 to 5.*

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

A vertical bar chart showing the percentage of patients reporting an improvement in erections across four treatment groups: Placebo, Sildenafil 25 mg, Sildenafil 50 mg, and Sildenafil 100 mg. The percentages increase progressively with dosage, with the 100 mg group showing the highest improvement.*

FDA Label Image

Structure (Sildenafil Str)

Chemical structure of Sildenafil shown as a molecular diagram with labeled functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.